Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

84.39 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 420
Open 84.39
Bid (Size) 84.26 (300)
Ask (Size) 84.40 (5,700)
Prev. Close 84.39
Today's Range 84.39 - 84.39
52wk Range 73.31 - 105.07
Shares Outstanding 2,531,374,696
Dividend Yield 3.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Reasons Investors Love Merck (MRK)
Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s 21.3% return during that period. This may have investors wondering how to... 
Via StockStory
Topics Stocks Supply Chain
MarketMinute: The Rise of Precision Swine Farming – A New Frontier in Agri-Tech Investment
The global agricultural landscape is undergoing a profound transformation, with specialized niche markets emerging as significant drivers of innovation and investment. Among these, the precision swine... 
Via MarketMinute
Topics Artificial Intelligence Supply Chain

Performance

YTD
-14.9%
-14.9%
1 Month
-5.0%
-5.0%
3 Month
+6.2%
+6.2%
6 Month
+6.7%
+6.7%
1 Year
-17.0%
-17.0%

More News

Read More
Obesity Drugmakers Face Shifting Tides: Novo Nordisk Plunges While Eli Lilly Soars
Via MarketMinute
Topics Economy
Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug
Via Stocktwits
Earnings Scheduled For October 30, 2025
Via Benzinga
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
Via TokenRing AI
Topics Artificial Intelligence Intellectual Property
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
Via TokenRing AI
Topics Artificial Intelligence
Why Merck Is Sinking This Week
Via The Motley Fool
Topics Intellectual Property
Merck Enters into Research and Development Funding Agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan (sac-TMT)
From Merck & Co., Inc.
Via Business Wire
Merck Signs Agreement with Dr. Falk Pharma GmbH for Certain Development and Commercialization Rights to MK-8690 (PRA-052) an Investigational Anti-CD30 Ligand Monoclonal Antibody
From Merck & Co., Inc.
Via Business Wire
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
Via The Motley Fool
Topics Energy Stocks
Merck Foundation Launches $22 Million Initiative to Improve Cardiovascular Care in the U.S.
From Merck Sharp & Dohme
Via Business Wire
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Via MarketMinute
Topics Intellectual Property
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Merck Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
Via Benzinga
Topics ETFs
Meta Tumbles 10%, Google Marks Historic Rally: What's Moving Markets Thursday?
Via Benzinga
Topics Economy
Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook
Via Benzinga
Merck’s (NYSE:MRK) Q3 Sales Top Estimates
Via StockStory
Merck & Co. Inc. (NYSE:MRK) Q3 2025 Earnings Beat Expectations Despite Stock Decline
Via Chartmill
Topics Earnings
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Dow Jones Stock Merck Tops Expectations, But Gardasil Challenges Remain
Via Investor's Business Daily
Topics Earnings Stocks
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 84.39
When was Merck & Co last traded?
The last trade of Merck & Co was at 11/05/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 213.62B
How many shares of Merck & Co are outstanding?
Merck & Co has 214B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.